Abstract
To report eye examinations findings and cost-efficiency of mobile eye and vision care screening in underserved areas in north India. The Aloka Vision Program combines optometrical and ophthalmological screening as mobile eye camps with organized referrals to local eye hospitals. 402 people from urban (N = 191) and rural (N = 211) areas in the district of Uttarakhand, India, were screened for refractive error (RE), visual acuity (VA) and eye health. Statistical analysis was performed using ANOVA model and odd ratios. Costs were estimated based on the expenses of the camps. 44 % of the participants were male and 56 % were female and the age ranged from 7 to 72 years (urban) and 7 to 80 years (rural). Lack of accessibility of eye care was mentioned by 10% of the urban and 47% of the rural participants, why not attending regular vision test. Mild and severe visual impairment VA < 0.5 logMAR affected every fifth person, independent from the living environment. RE showed a myopic trend for the urban environment (Δ M = 0.67 D, p = 0.11). The risk for blindness was three times higher in rural compared to the urban area, mainly caused by cataract. The major costs are given by the treatments (58 %), followed by mobilization and organization (∼30 %), whereas personal costs are low (∼11%). Combined eye and vision care models reduce costs for separated screening’s organization and thus can increase the effectiveness of eye screening programs significantly.
Competing Interest Statement
S. Wahl and A. Leube are scientists at the University Tuebingen. S. Wahl, A. Leube and J. Kuss are employees of Carl Zeiss Vision International GmbH. P. Moodbidri is employee of Carl Zeiss India Pvt. Ltd. R. Dhasmana is an ophthalmologist at the Himalayan Institute of Medical Science.
Clinical Trial
The current study reports on a case-finding screening program, not a clinical trial. Therefore, we have no Clinical Trial ID.
Funding Statement
This work was supported by the Excellence Initiative of the German government (ZUK63), and Carl Zeiss Vision International GmbH.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We have the certificate of approval from the institutional ethics committee of the Emmanuel Hospital Association, New Delhi, India for the remote eye screening study of the Aloka program in general (protocol number 209, see below the ethics proposal and the certificate approval are attached). Prior to the participation in the study, the screening protocol included an informed consent which was provided to the participants or in case of age under 18 by a parent or legal guardian. Further, the rationales of the study in accordance with the Declaration of Helsinki. Ethical considerations were ensured, since the Aloka Vision Program is part of the general eye camps performed by the eye doctors from the Himalayan Institute of Medical Sciences, Department of Ophthalmology.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data is available in the Ophthalmic Research Institute, University Tuebingen, Germany.
